Need to increase Congressional oversight on autism research and related issues.
Duration: January 1, 2014
to
June 30, 2015
General Issues: Government Issues , Health Issues , Science/Technology , Chemicals/Chemical Industry , Consumer Issues/Safety/Protection , Medical/Disease Research/Clinical Labs , Environmental/Superfund , Education , Housing , Medicare/Medicaid , Veterans , Defense , Civil Rights/Civil Liberties
Spending: about $18,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2014: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ), State - Dept of (DOS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Beth Clay House Oversight & Government Reform Comm- Sr. Prof Staff
Senior Professional Staff, House Committee on Government Reform and Oversight (1998-2003)
Senior Professional Staff, House Committee on Government Reform and Overesight (1998-2003)
House Gov Ref & Oversight - Sr. Prof. Staff
Senior Professional Staff, House Oversight Committee
Senior Professional Staff, US House of Representatives, Government Reform and Oversight Committee (1998-2003)
Beth Clays Senior Professional Staff, House Oversight Committee
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2015
Hawk International, LLC terminated an engagement in which they represented SafeMinds on Dec. 30, 2015.
Original Filing: 300768741.xml
Lobbying Issues
Need to increase Congressional oversight on autism research and related issues.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
Hawk International, LLC terminated an engagement in which they represented SafeMinds on Aug. 6, 2015.
Original Filing: 300748663.xml
Lobbying Issues
Need to increase Congressional oversight on autism research and related issues.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Hawk International, LLC lobbied for SafeMinds , earning $6,000. The report was filed on Aug. 6, 2015.
Original Filing: 300748662.xml
Lobbying Issues
Autism research and services. Environmental factors related to autism and need for increased and improved research. Removal of mercury from FDA regulated products.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Need to increase Congressional oversight on autism research and related issues.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
Hawk International, LLC amended a lobbying report for representation of SafeMinds in Q12015 on Aug. 6, 2015.
Original Filing: 300748665.xml
Lobbying Issues
Autism research and services. Environmental factors related to autism and need for increased and improved research. Removal of mercury from FDA regulated products.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Need to increase Congressional oversight on autism research and related issues.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Hawk International, LLC lobbied for SafeMinds , earning $6,000. The report was filed on Aug. 6, 2015.
Original Filing: 300748656.xml
Lobbying Issues
Autism related matters including research focus, environmental factors associated with epidemic increase in autism, and need for improved Congressional oversight. Also concern about continued use of mercury in FDA regulated products including prescription drugs and biologics.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Need for improved Congressional oversight in autism, vaccine injury compensation program, and vaccine policies. Need to insure only thimerosal free vaccines are given to pregnant women and infants.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, Hawk International, LLC lobbied for SafeMinds , earning $6,000. The report was filed on Aug. 6, 2015.
Original Filing: 300748661.xml
Lobbying Issues
Autism Spectrum Disorders research, services and treatments; Removal of Mercury in Medicines; Vaccine Injury Compensation Program Reform;
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research related to autism spectrum disorders, the diagnosis and treatment of heavy metal exposures, and the issues of conflicts of issues in research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued use of Mercury in vaccines and other medicines.
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Need for improves autism research, focused on environmental factors.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2014
Hawk International, LLC amended a lobbying report for representation of SafeMinds in Q32014 on Aug. 6, 2015.
Original Filing: 300748666.xml
Lobbying Issues
Autism Spectrum Disorders research, services and treatments; Removal of Mercury in Medicines; Vaccine Injury Compensation Program Reform;
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research related to autism spectrum disorders, the diagnosis and treatment of heavy metal exposures, and the issues of conflicts of issues in research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued use of Mercury in vaccines and other medicines.
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Need for improves autism research, focused on environmental factors.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2014
Hawk International, LLC amended a lobbying report for representation of SafeMinds in Q22014 on Aug. 6, 2015.
Original Filing: 300748664.xml
Lobbying Issues
Autism Spectrum Disorders research, services and treatments; Removal of Mercury in Medicines; Vaccine Injury Compensation Program Reform;
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research related to autism spectrum disorders, the diagnosis and treatment of heavy metal exposures, and the issues of conflicts of issues in research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued use of Mercury in vaccines and other medicines.
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Need for improves autism research, focused on environmental factors.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2014
In Q2, Hawk International, LLC lobbied for SafeMinds . The report was filed on July 31, 2014.
Original Filing: 300671362.xml
Lobbying Issues
Autism Spectrum Disorders research, services and treatments; Removal of Mercury in Medicines; Vaccine Injury Compensation Program Reform;
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research related to autism spectrum disorders, the diagnosis and treatment of heavy metal exposures, and the issues of conflicts of issues in research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued use of Mercury in vaccines and other medicines.
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Need for improves autism research, focused on environmental factors.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2014
In Q1, Hawk International, LLC lobbied for SafeMinds . The report was filed on May 6, 2014.
Original Filing: 300651223.xml
Lobbying Issues
Autism Spectrum Disorders research, services, treatments, programs and related legislation and oversight activities. Mercury Treaty, mercury regulation, mercury/thimerosal and other toxicants in medicines and household products. Vaccine Injury Compensation Program reform, improved vaccine safety and adverse events evaluation research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Autism Spectrum Disorders
Mercury/Thimersoal
Vaccine Injury
Agencies Lobbied
U.S. Senate
Lobbying Issues
Autism Spectrum Disorders, need for expanded and improved research addressing environmental factors associated with autism epidemic.
Need for increased, ongoing Congressional oversight in autism matters.
Concern about continued use of thimerosal (mercury) containing vaccines in pregnant women and infants.
Status of extradition of autism-vaccine injury researcher fugitive Poul Thorsen from Denmark
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2014
Hawk International, LLC filed a lobbying registration on Jan. 6, 2014 to represent SafeMinds, effective Jan. 1, 2014.
Original Filing: 300612187.xml
Issue(s) they said they’d lobby about: Autism spectrum disorders research, services, programs and related legislation and oversight activities.
Mercury Treaty, mercury regulation. mercury/thimerosal and other toxicants in medicines and household products.
Vaccine Injury Compensation Program; vaccine safety, and adverse event evaluation research. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...